Anest. intenziv. Med. 2008;19(4):187-189
Last case of halothan hepatitis in the Czech Republic? Case reportAnaesthesiology - Case Reports
- 1 Klinika anesteziologie, resuscitace a intenzivní péče IKEM
- 2 Klinika hepatogastroenterologie IKEM
- 3 Transplantcentrum IKEM
We describe a case of a 49 years old female patient with acute liver failure caused by halothan induced hepatitis. The liver failure was so severe that she was indicated for liver transplantation. The successful outcome of liver transplantation was facilitated also by supportive treatment with fractionated plasma separation and adsorption (FPSA) on Prometheus® device.
Keywords: halothan hepatitis; liver transplantation; Prometheus
Received: March 29, 2008; Accepted: June 12, 2008; Published: August 1, 2008 Show citation
References
- Ray, D. C., Drummond, G. B. Halothane hepatitis. Br. J. Anaesth., 1991, 67, p. 84-89.
Go to original source...
Go to PubMed...
- Kenna, J. G., Knight, T. L., van Pelt, FNAM. Immunity of halothane metabolite-modified proteins in halothane hepatitis. Ann. NY. Acad. Sci., 1993, 685, p. 646-661.
Go to original source...
Go to PubMed...
- Bourdi, M. et al. Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis. Chemical Research in Toxicology, 1996, 7, p. 1159-1166.
Go to original source...
Go to PubMed...
- Rifai, K. et al. Prometheus - new extracoporeal system for treatment of liver failure. J. Hepatol., 2003, 39, p. 984-990.
Go to original source...
Go to PubMed...
- O'Grady, J. G., Alexander, G. J., Hayllar, K. M., Williams, R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology, 1989, 97, p. 439-445.
Go to original source...
Go to PubMed...
- Kieslichová, E. et al. Úspěšná léčba akutního selhání jater pomocí přístrojové podpůrné terapie s následnou transplantací jater. Prakt. Lék., 2006, 86, No. 5, p. 275-277.